From February 5, 2024 to March 31, 2024, the company has repurchased 10,000 shares, representing 0.01% for CNY 0.25 million. With this, the company has completed the repurchase of 10,000 shares, representing 0.01% for CNY 0.25 million under the buyback announced on February 6, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.9 CNY | +0.57% | -3.98% | -7.37% |
1st Jan change | Capi. | |
---|---|---|
-7.37% | 378M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- 301258 Stock
- News Suzhou Fushilai Pharmaceutical Co., Ltd.
- Tranche Update on Suzhou Fushilai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024.